293 related articles for article (PubMed ID: 12627713)
1. Immunohistochemical detection of uroplakin III, cytokeratin 7, and cytokeratin 20 in canine urothelial tumors.
Ramos-Vara JA; Miller MA; Boucher M; Roudabush A; Johnson GC
Vet Pathol; 2003 Jan; 40(1):55-62. PubMed ID: 12627713
[TBL] [Abstract][Full Text] [Related]
2. Uroplakin-III to distinguish primary vulvar Paget disease from Paget disease secondary to urothelial carcinoma.
Brown HM; Wilkinson EJ
Hum Pathol; 2002 May; 33(5):545-8. PubMed ID: 12094381
[TBL] [Abstract][Full Text] [Related]
3. Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas.
Parker DC; Folpe AL; Bell J; Oliva E; Young RH; Cohen C; Amin MB
Am J Surg Pathol; 2003 Jan; 27(1):1-10. PubMed ID: 12502922
[TBL] [Abstract][Full Text] [Related]
4. Differences in expression of uroplakin III, cytokeratin 7, and cyclooxygenase-2 in canine proliferative urothelial lesions of the urinary bladder.
Sledge DG; Patrick DJ; Fitzgerald SD; Xie Y; Kiupel M
Vet Pathol; 2015 Jan; 52(1):74-82. PubMed ID: 24608632
[TBL] [Abstract][Full Text] [Related]
5. Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma.
Bassily NH; Vallorosi CJ; Akdas G; Montie JE; Rubin MA
Am J Clin Pathol; 2000 Mar; 113(3):383-8. PubMed ID: 10705819
[TBL] [Abstract][Full Text] [Related]
6. Expression of cell cycle regulators, 14-3-3σ and p53 proteins, and vimentin in canine transitional cell carcinoma of the urinary bladder.
Suárez-Bonnet A; Herráez P; Aguirre M; Suárez-Bonnet E; Andrada M; Rodríguez F; Espinosa de Los Monteros A
Urol Oncol; 2015 Jul; 33(7):332.e1-7. PubMed ID: 25979650
[TBL] [Abstract][Full Text] [Related]
7. [Uroplakin III, a specific membrane protein of urothelial umbrella cells, as a histological markers for metastatic transitional cell carcinomas].
Moll R; Laufer J; Wu XR; Sun TT
Verh Dtsch Ges Pathol; 1993; 77():260-5. PubMed ID: 7511294
[TBL] [Abstract][Full Text] [Related]
8. Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins.
Riedel I; Czernobilsky B; Lifschitz-Mercer B; Roth LM; Wu XR; Sun TT; Moll R
Virchows Arch; 2001 Feb; 438(2):181-91. PubMed ID: 11253121
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical Expression of Cyclin D1, Cytokeratin 20, and Uroplakin III in Proliferative Urinary Bladder Lesions Induced by o-Nitroanisole in Fischer 344/N Rats.
Willson CJ; Flake GP; Sills RC; Kissling GE; Cesta MF
Vet Pathol; 2016 May; 53(3):682-90. PubMed ID: 26319780
[TBL] [Abstract][Full Text] [Related]
10. Uroplakin expression in the urothelial tumors of cows.
Ambrosio V; Borzacchiello G; Bruno F; Galati P; Roperto F
Vet Pathol; 2001 Nov; 38(6):657-60. PubMed ID: 11732799
[TBL] [Abstract][Full Text] [Related]
11. Coordinate expression of cytokeratins 7 and 20 in feline and canine carcinomas.
Espinosa de los Monteros A; Fernández A; Millán MY; Rodríguez F; Herráez P; Martín de las Mulas J
Vet Pathol; 1999 May; 36(3):179-90. PubMed ID: 10332826
[TBL] [Abstract][Full Text] [Related]
12. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
Tamas EF; Epstein JI
Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
[TBL] [Abstract][Full Text] [Related]
13. Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines.
Moll R; Achtstätter T; Becht E; Balcarova-Ständer J; Ittensohn M; Franke WW
Am J Pathol; 1988 Jul; 132(1):123-44. PubMed ID: 2456018
[TBL] [Abstract][Full Text] [Related]
14. Different immunohistochemical and ultrastructural phenotypes of squamous differentiation in bladder cancer.
Gaisa NT; Braunschweig T; Reimer N; Bornemann J; Eltze E; Siegert S; Toma M; Villa L; Hartmann A; Knuechel R
Virchows Arch; 2011 Mar; 458(3):301-12. PubMed ID: 21136076
[TBL] [Abstract][Full Text] [Related]
15. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study.
Samaratunga H; Khoo K
Histopathology; 2004 Jul; 45(1):55-64. PubMed ID: 15228444
[TBL] [Abstract][Full Text] [Related]
16. Cytokeratin 20: a new marker for early detection of bladder cell carcinoma?
Buchumensky V; Klein A; Zemer R; Kessler OJ; Zimlichman S; Nissenkorn I
J Urol; 1998 Dec; 160(6 Pt 1):1971-4. PubMed ID: 9817302
[TBL] [Abstract][Full Text] [Related]
17. Differential immunocytochemical staining patterns of uroplakin observed on neoplastic and nonneoplastic tissue fragments obtained from upper urinary tract brush specimens.
Xu X; Genega EM; Nasuti JF
Acta Cytol; 2002; 46(4):684-9. PubMed ID: 12146031
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of keratin proteins in urinary bladder carcinoma.
Asamoto M; Fukushima S; Tatemoto Y; Yamada K; Fukui S; Mori M
Pathol Res Pract; 1989 Feb; 184(2):194-201. PubMed ID: 2469067
[TBL] [Abstract][Full Text] [Related]
19. Cytokeratin 7 and cytokeratin 20 in primary urinary bladder carcinoma and matched lymph node metastasis.
Jiang J; Ulbright TM; Younger C; Sanchez K; Bostwick DG; Koch MO; Eble JN; Cheng L
Arch Pathol Lab Med; 2001 Jul; 125(7):921-3. PubMed ID: 11419977
[TBL] [Abstract][Full Text] [Related]
20. Immunoreactivity of p63 in monolayered and in vitro stratified human urothelial cell cultures compared with native urothelial tissue.
Feil G; Maurer S; Nagele U; Krug J; Bock C; Sievert KD; Stenzl A
Eur Urol; 2008 May; 53(5):1066-72. PubMed ID: 17980954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
